Benralizumab: Effectiveness in Patients with Uncontrolled Severe Eosinophilic Asthma at 6 and 12 Months at a Third-Level Care Hospital. Capacity for ICS-LABA Therapy Reduction
Yair Humberto González-Tuyub,1 Karla Daniela González-Iñiguez,1 Paula Catalina Lizarazo-Guiza,2 Sergio Ricardo García-García3 1Clinical Immunology and Allergy Service, ISSSTE Hospital Regional General, Ignacio Zaragoza, Ciudad de México, México; 2Medical Scientific Liaison, AstraZeneca, Ciudad de Mé...
Saved in:
| Main Authors: | González-Tuyub YH, González-Iñiguez KD, Lizarazo-Guiza PC, García-García SR |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-11-01
|
| Series: | Journal of Asthma and Allergy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/benralizumab-effectiveness-in-patients-with-uncontrolled-severe-eosino-peer-reviewed-fulltext-article-JAA |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Benralizumab Depletes IL‐5Rα‐Bearing Cells in Skin Lesions of Patients With Atopic Dermatitis
by: Christiane E. Whetstone, et al.
Published: (2025-08-01) -
The effects of benralizumab on lung volume changes during exercise in experimental setting in severe asthmatics: a pilot study
by: Alida Benfante, et al.
Published: (2025-07-01) -
Use, Effectiveness, and Safety of Inhaler Devices for LABA/LAMA Fixed-Dose Combinations in Patients with COPD
by: Sara Lopes, et al.
Published: (2025-05-01) -
FIP1L1‐PDGFRA Positive Chronic Eosinophilic Leukemia Presenting With Vestibular Neuritis
by: Ahmad Abu‐Zahra, et al.
Published: (2025-06-01) -
Serum and nasal lavage fluid eosinophil-derived neurotoxin levels and their determinants in adults
by: Saliha Selin Özuygur Ermis, MD, et al.
Published: (2025-08-01)